Suppr超能文献

急性肾损伤在重症监护病房行肾脏替代治疗的特征和结局的时间变化:日本全国行政数据库的分析,2007-2016 年。

Temporal change in characteristics and outcomes of acute kidney injury on renal replacement therapy in intensive care units: analysis of a nationwide administrative database in Japan, 2007-2016.

机构信息

Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.

Department of Health Services Research, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

出版信息

Crit Care. 2019 May 15;23(1):172. doi: 10.1186/s13054-019-2468-8.

Abstract

BACKGROUND

We aimed to examine recent trends in patient characteristics and mortality in patients with acute kidney injury (AKI) receiving renal replacement therapy (RRT), including continuous RRT (CRRT) and intermittent RRT (IRRT), in intensive care units (ICUs).

METHODS

From the Diagnosis Procedure Combination database in Japan during 6 months (July-December) from 2007 to 2016, we identified patients with AKI who received RRT in ICUs. We restricted the study participants to those admitted to hospitals (in which both CRRT and IRRT were available) that participated in the Diagnosis Procedure Combination database for all 10 years. We examined the trends in patient characteristics and mortality overall, by RRT modality, and by main diagnosis category subgroup. Logistic regression was used to adjust for patient characteristics.

RESULTS

We identified 51,758 patients starting RRT in 287 hospitals, including 39,471 (76.3%) and 12,287 (23.7%) patients starting CRRT and IRRT. The crude in-hospital mortality declined from 44.9 to 36.1% (P for trend < 0.001). Compared with 2007, the adjusted odds ratio (aOR) for in-hospital mortality was 0.66 (95% confidence interval (CI) 0.60-0.72) in 2016, and the decreasing trend was observed in both patients starting CRRT (aOR 0.67, 95% CI 0.61-0.75) and IRRT (0.58, 0.45-0.74), and in all subgroups except for coronary artery disease: sepsis aOR 0.68 (95% CI 0.57-0.81); cardiovascular surgery 0.58 (0.45-0.76); coronary artery disease 0.84 (0.60-1.19); non-coronary heart disease 0.78 (0.64-0.94); central nervous system disorders 0.42 (0.28-0.62); trauma 0.39 (0.21-0.72); and other 0.64 (0.50-0.82).

CONCLUSIONS

This nationwide study confirmed a consistent decline in mortality among patients with AKI on RRT in ICUs. The adjusted mortality also declined during the study period; however, physiological variables were not measured in this study and it is possible that RRT may have been indicated for patients with less severe AKI in more recent years.

摘要

背景

我们旨在研究接受肾脏替代治疗(RRT)的急性肾损伤(AKI)患者的近期特征和死亡率趋势,包括连续性肾脏替代治疗(CRRT)和间歇性肾脏替代治疗(IRRT),研究对象为重症监护病房(ICU)中的患者。

方法

我们从日本的诊断程序组合数据库中选择了 2007 年至 2016 年 6 个月(7 月至 12 月)期间接受 ICU 中 RRT 的 AKI 患者。我们将研究对象限定为在参与诊断程序组合数据库的所有 10 年的医院(均提供 CRRT 和 IRRT)中住院的患者。我们通过 RRT 方式和主要诊断类别亚组来检查患者特征和死亡率的趋势。使用逻辑回归调整患者特征。

结果

我们在 287 家医院中确定了 51758 例开始 RRT 的患者,其中 39471 例(76.3%)和 12287 例(23.7%)开始接受 CRRT 和 IRRT。住院死亡率从 44.9%下降至 36.1%(趋势 P<0.001)。与 2007 年相比,2016 年住院死亡率的调整后比值比(aOR)为 0.66(95%置信区间[CI]0.60-0.72),且在接受 CRRT 的患者(aOR 0.67,95%CI 0.61-0.75)和接受 IRRT 的患者(0.58,0.45-0.74)以及除冠状动脉疾病以外的所有亚组中均观察到下降趋势:脓毒症 aOR 0.68(95%CI 0.57-0.81);心血管手术 aOR 0.58(0.45-0.76);冠状动脉疾病 aOR 0.84(0.60-1.19);非冠心病 aOR 0.78(0.64-0.94);中枢神经系统疾病 aOR 0.42(0.28-0.62);创伤 aOR 0.39(0.21-0.72);以及其他 aOR 0.64(0.50-0.82)。

结论

这项全国性研究证实,重症监护病房中接受肾脏替代治疗的 AKI 患者的死亡率持续下降。在研究期间,调整后的死亡率也有所下降;然而,本研究未测量生理变量,并且近年来 RRT 可能被用于治疗 AKI 程度较轻的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e6/6521368/2ee252282047/13054_2019_2468_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验